UNITED STATES OF AMERICA ex rel. JOHN A. WOOD, and on behalf of the STATES of CALIFORNIA v. ALLERGAN, INC.

CourtDistrict Court, S.D. New York
DecidedJune 10, 2020
Docket1:19-cv-04029
StatusUnknown

This text of UNITED STATES OF AMERICA ex rel. JOHN A. WOOD, and on behalf of the STATES of CALIFORNIA v. ALLERGAN, INC. (UNITED STATES OF AMERICA ex rel. JOHN A. WOOD, and on behalf of the STATES of CALIFORNIA v. ALLERGAN, INC.) is published on Counsel Stack Legal Research, covering District Court, S.D. New York primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook
UNITED STATES OF AMERICA ex rel. JOHN A. WOOD, and on behalf of the STATES of CALIFORNIA v. ALLERGAN, INC., (S.D.N.Y. 2020).

Opinion

SOUTHERN DISTRICT OF NEW YORK -----------------------------------------------------------------------X- : UNITED STATES ex rel. JOHN A. WOOD et al., : : Plaintiffs, : 19-CV-4029 (JMF) : -v- : OPINION AND ORDER : ALLERGAN, INC., : : Defendant. : : ---------------------------------------------------------------------- X

JESSE M. FURMAN, United States District Judge: This is Plaintiff-Relator John A. Wood’s third effort to bring claims against Defendant Allergan, Inc. (“Allergan”), under the False Claims Act (“FCA”), 31 U.S.C. §§ 3729 et seq., and various state analogs. Following an interlocutory appeal, the Court dismissed Wood’s first suit eight years after it had initially been filed pursuant to the FCA’s first-to-file rule. See id. § 3730(b)(5). Shortly thereafter, he filed a second suit, but quickly voluntarily dismissed it in the face of Allergan’s contention that it, too, violated the first-to-file rule. Adhering to the adage that “if at first you don’t succeed, try, try again,” Wood now tries for a third time. But while his third effort clears the first-to-file hurdle, it runs headlong into another obstacle: timeliness. For the reasons that follow, the Court agrees with Allergan that Wood’s federal claims are time barred and that he is not entitled to equitable tolling for the six years it took for the Government to investigate and decide not to intervene. Accordingly, his FCA claims are dismissed, and the Court declines to exercise supplemental jurisdiction over his state-law claims. BACKGROUND The Court assumes familiarity with the background of this litigation, which is described at length in this Court’s prior opinion, see United States ex rel. Wood v. Allergan, Inc., 246 F. appeal, see United States ex rel. Wood v. Allergan, Inc., 899 F.3d 163, 166-68 (2d Cir. 2018).

Briefly stated, Wood alleges that Allergan violated the FCA and state-law analogs through a kickback scheme that spanned from 2003 to 2011. See ECF No. 8 (“Compl.”), ¶¶ 39, 260; see also Wood I, 246 F. Supp. 3d at 784. Wood also alleges that Allergan terminated him on July 6, 2010, in retaliation for engaging in protected activity under the FCA. See Compl. ¶ 266. Wood filed his first action asserting these claims nearly ten years ago, on July 26, 2010. See Wood I, 246 F. Supp. 3d at 786. At the time, two other suits alleging the same kickback scheme were pending under seal in other federal courts. See id. Accordingly, Wood’s first suit violated the FCA’s first-to-file rule, which provides that “[w]hen a person brings a [qui tam action under 31 U.S.C. § 3730(b)], no person other than the Government may intervene or bring a related action based on the facts underlying the pending action.” 31 U.S.C. § 3730(b)(5). In

2012, however, the two earlier-filed cases were unsealed and dismissed. See Wood I, 246 F. Supp. 3d at 786. Thus, when the Government decided in March 2016 not to intervene in Wood I and the case was unsealed, there was no longer another action “pending.” Id. On August 4, 2016, Allergan moved to dismiss Wood’s operative complaint in Wood I, citing the first-to-file rule. Id. at 787. In a lengthy opinion addressing an issue of first impression in the Second Circuit, but on which other courts had divided, this Court held that, because the two earlier-filed actions had been dismissed, Wood could cure his first-to-file violation simply by amending his complaint. See id. at 793-800 (citing cases reflecting the “radically different approaches” taken by federal courts on the issue, including Gadbois v.

PharMerica Corp., 809 F.3d 1, 6 (1st Cir. 2015), which held that the district court had discretion to allow cure by amendment). On May 4, 2017, the Court certified the issue for interlocutory appeal, see Docket No. 10-CV-5645 (“Wood I Docket”), ECF No. 124, and thereafter approved an agreement between the parties to toll “[a]ny and all limitation of action time periods (e.g., mandate in connection with the interlocutory appeal, see Wood I Docket, ECF No. 128.

On August 9, 2018, the Second Circuit reversed, holding that Wood could not cure the initial first-to-file violation by amending his complaint, and directed this Court to dismiss the action without prejudice on remand. See Wood, 899 F.3d at 175. On October 3, 2018, two days after the Second Circuit’s mandate issued, the Court dismissed Wood I. See Wood I Docket, ECF Nos. 139-40. Approximately three weeks later, on October 25, 2018, Wood filed his second suit (“Wood II”), alleging the same claims he had alleged in Wood I. See Docket No. 18- CV-9857 (JMF) (“Wood II Docket”), ECF No. 1; ECF No. 32 (“Opp’n”), at 6. On February 8, 2019, Allergan moved to dismiss, arguing (among other things) that Wood II violated the first-to- file bar because the time for Wood to petition the Supreme Court for review of the Second Circuit’s decision had not yet expired and Wood I was therefore still “pending.” Wood II

Docket, ECF No. 29, at 3-8. On March 1, 2019, Wood moved to voluntarily dismiss Wood II “to avoid any further litigation over the first-to-file bar that might delay resolution of his claims.” Wood II Docket, ECF Nos. 32-33; Opp’n 6-7. The Court dismissed Wood II on March 11, 2019. Wood II Docket, ECF No. 38. Less than two months later, on May 6, 2019, Wood filed the pending action, pressing the same claims that he had pressed in Wood I and Wood II. Allergan now moves, pursuant to Rule 12(b)(6) of the Federal Rules of Civil Procedure, to dismiss on the ground that Wood’s FCA claims are untimely. See ECF No. 26 (“Def.’s Mem.”), at 5-17. DISCUSSION

Under 31 U.S.C. § 3731(b), a qui tam action under the FCA may not be brought — (1) more than 6 years after the date on which the violation of section 3729 is committed, or known or reasonably should have been known by the official of the United States charged with responsibility to act in the circumstances, but in no event more than 10 years after the date on which the violation is committed, whichever occurs last. Wood concedes that, on its face, this provision bars his FCA claims, as those claims are based on conduct that occurred between 2003 and 2011 and “facts material to” the claims were known to the Government no later than July 26, 2010, when Wood I was filed. See Opp’n 1. Nevertheless, he opposes Allergan’s motion on the ground that he is entitled to equitable tolling of the limitations period as of July 26, 2010. See id. “Equitable tolling,” he alleges in the Complaint, “is appropriate in circumstances such as this, in which the plaintiff proceeded diligently but was prevented from proceeding with the action based on extraordinary circumstances beyond the plaintiff’s control” — namely, “the statutory requirement that Relator Wood’s complaint remain under seal for a period of six years while the Government investigated his claims before making its intervening decision.” Compl. ¶ 283. In deciding whether Wood is entitled to equitable tolling, the threshold question is whether Section 3731(b) is a statute “of limitation,” a statute “of repose,” or a hybrid. Cal. Pub. Emps.’ Ret. Sys. v. ANZ Sec., Inc., 137 S. Ct. 2042, 2049 (2017). The distinction between statutes of limitation and statutes of repose is important because the former are generally subject

to equitable tolling, while the latter are not. See Pasternack v.

Free access — add to your briefcase to read the full text and ask questions with AI

Related

United Mine Workers of America v. Gibbs
383 U.S. 715 (Supreme Court, 1966)
Carnegie-Mellon University v. Cohill
484 U.S. 343 (Supreme Court, 1988)
Young v. United States
535 U.S. 43 (Supreme Court, 2002)
Jenkins v. Greene
630 F.3d 298 (Second Circuit, 2010)
Harper v. Ercole
648 F.3d 132 (Second Circuit, 2011)
Federal Housing Finance Agency v. UBS Americas Inc.
712 F.3d 136 (Second Circuit, 2013)
United States v. Community Health Systems, Inc.
501 F.3d 493 (Sixth Circuit, 2007)
United States v. Incorporated Village of Island Park
791 F. Supp. 354 (E.D. New York, 1992)
Roy v. Buffalo Philharmonic Orchestra
684 F. App'x 22 (Second Circuit, 2017)
Pasternack v. Shrader
863 F.3d 162 (Second Circuit, 2017)
Watson v. United States
865 F.3d 123 (Second Circuit, 2017)

Cite This Page — Counsel Stack

Bluebook (online)
UNITED STATES OF AMERICA ex rel. JOHN A. WOOD, and on behalf of the STATES of CALIFORNIA v. ALLERGAN, INC., Counsel Stack Legal Research, https://law.counselstack.com/opinion/united-states-of-america-ex-rel-john-a-wood-and-on-behalf-of-the-states-nysd-2020.